Genelabs complies with Nasdaq minimum share price requirement

By Ted A. Knutson

Washington, Jan. 9 - Genelabs Technologies, Inc. said Monday it has received notification from The Nasdaq Stock Market that the company has regained compliance with the $1.00-per-share minimum closing bid price requirement for continued listing on the Nasdaq Capital Market.

Redwood City, Calif.-based Genelabs is a biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.